Article: Biomanufacturing Without the Big Bioreactors Learn about J.POD®, our new cGMP manufacturing facility for biologics. Learn More
Webinar: Comprehensive and integrated formulation drug development Our early formulation experts will take you through how having an integrated formulation strategy from… Learn More
Webinar: 5 challenging cases for Evotec’s early formulation experts Ready to solve your bioavailability challenges? Watch our webinar to learn more from our formulation… Learn More
Read our Nature Publication on Eliapixant, a Selective P2X3 Receptor Antagonist Learn about our latest research on a selective P2X3 receptor antagonist for the treatment of… Learn More
Transforming Toxicology Prediction using Panomics Learn about transcriptomics and how the technology is transforming DILI and toxicology prediction. Learn More
CARMA FUND I Completes First Closing of € 47 m to Accelerate the Transfer of Life-Science Research into Practice June 20, 2022 Learn more